Literature DB >> 14628943

Induction of severe disease in hamsters by two sandfly fever group viruses, Punta toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus.

Ann F Fisher1, Robert B Tesh, Jessica Tonry, Hilda Guzman, Dongying Liu, Shu-Yuan Xiao.   

Abstract

Adult golden hamsters inoculated subcutaneously with either of two sandfly fever group viruses, Punta Toro and Gabek Forest (Phlebovirus, Bunyaviridae), developed a fulminating fatal illness characterized by hepatic and splenic necrosis and interstitial pneumonitis. Most animals died within three days after infection; this was accompanied by high levels of viremia. Necropsy and histopathologic examination of the infected animals revealed pathologic changes involving multiple organs that resembled those described in Rift Valley fever. These two hamster-phlebovirus systems may serve as alternative animal models for Rift Valley fever and should be useful in studying the pathogenesis of severe phlebovirus infection and for testing potential therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14628943

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  25 in total

1.  Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model.

Authors:  Cong Jin; Mifang Liang; Junyu Ning; Wen Gu; Hong Jiang; Wei Wu; Fushun Zhang; Chuan Li; Quanfu Zhang; Hua Zhu; Ting Chen; Ying Han; Weilun Zhang; Shuo Zhang; Qin Wang; Lina Sun; Qinzhi Liu; Jiandong Li; Tao Wang; Qiang Wei; Shiwen Wang; Ying Deng; Chuan Qin; Dexin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters.

Authors:  Brian B Gowen; Donald F Smee; Min-Hui Wong; John W Judge; Kie-Hoon Jung; Kevin W Bailey; Anne M Pace; Barnett Rosenberg; Robert W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 3.  Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.

Authors:  Brian B Gowen; Brady T Hickerson
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

4.  Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.

Authors:  Shoko Nishiyama; Olga A L Slack; Nandadeva Lokugamage; Terence E Hill; Terry L Juelich; Lihong Zhang; Jennifer K Smith; David Perez; Bin Gong; Alexander N Freiberg; Tetsuro Ikegami
Journal:  Virulence       Date:  2016-06-01       Impact factor: 5.882

5.  The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist.

Authors:  Lucy A Perrone; Krishna Narayanan; Melissa Worthy; C J Peters
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

6.  Development of a novel nonhuman primate model for Rift Valley fever.

Authors:  Darci R Smith; Brian H Bird; Bridget Lewis; Sara C Johnston; Sarah McCarthy; Ashley Keeney; Miriam Botto; Ginger Donnelly; Joshua Shamblin; César G Albariño; Stuart T Nichol; Lisa E Hensley
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

7.  Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.

Authors:  Dionna Scharton; Kevin W Bailey; Zachary Vest; Jonna B Westover; Yohichi Kumaki; Arnaud Van Wettere; Yousuke Furuta; Brian B Gowen
Journal:  Antiviral Res       Date:  2014-01-31       Impact factor: 5.970

8.  Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response.

Authors:  Michelle Mendenhall; Min-Hui Wong; Ramona Skirpstunas; John D Morrey; Brian B Gowen
Journal:  Virology       Date:  2009-09-26       Impact factor: 3.616

9.  Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models.

Authors:  Brian B Gowen; Min-Hui Wong; Kie-Hoon Jung; Donald F Smee; John D Morrey; Yousuke Furuta
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

10.  Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: importance of liposomal delivery and CpG motifs.

Authors:  Brian B Gowen; Jeff Fairman; Steven Dow; Ryan Troyer; Min-Hui Wong; Kie-Hoon Jung; Peter C Melby; John D Morrey
Journal:  Antiviral Res       Date:  2008-10-07       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.